MRKR
Marker Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.03
+4.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.99x
- P/S forward
- 3.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.41x
- Price / sales
- 13.93x
- Price / cash flow
- -1.76x
Enterprise value
- Enterprise value
- $5.8M
- EV / sales
- 4.74x
- EV / EBITDA
- -0.67x
- EV / EBIT
- -0.55x
- Market cap
- $17.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026